Literature DB >> 21596055

Cognitive enhancers for the treatment of ADHD.

L Cinnamon Bidwell1, F Joseph McClernon, Scott H Kollins.   

Abstract

Attention-deficit hyperactivity disorder (ADHD) is associated with multiple cognition-related phenotypic features in both children and adults. This review aims to clarify the role of cognition in ADHD and how prevailing treatments, which are often highly effective at reducing the clinical symptoms of the disorder, fare in modulating ADHD-related cognitive processes. First, we consider how the broad construct of cognition can be conceptualized in the context of ADHD. Second, we review the available evidence for how a range of both pharmacological and non-pharmacological interventions have fared with respect to enhancing cognition in individuals affected by this pervasive disorder. Findings from the literature suggest that the effects across a broad range of pharmacological and non-pharmacological interventions on the characteristic symptoms of ADHD can be distinguished from their effects on cognitive impairments. As such the direct clinical relevance of cognition enhancing effects of different interventions is somewhat limited. Recommendations for future research are discussed, including the identification of cognition-related endophenotypes, the refinement of the ADHD clinical phenotype, and studying the difference between acute and chronic treatment regimens.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21596055      PMCID: PMC3353150          DOI: 10.1016/j.pbb.2011.05.002

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  201 in total

Review 1.  Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions.

Authors:  Amy F T Arnsten; Bao-Ming Li
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

2.  The effect of alpha-2 adrenergic agonists on memory and cognitive flexibility.

Authors:  Youngjee Choi; John C Novak; Ashleigh Hillier; Nicholas A Votolato; David Q Beversdorf
Journal:  Cogn Behav Neurol       Date:  2006-12       Impact factor: 1.600

Review 3.  Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder.

Authors:  Aaron P Gibson; Tawny L Bettinger; Nick C Patel; M Lynn Crismon
Journal:  Ann Pharmacother       Date:  2006-05-30       Impact factor: 3.154

4.  A pilot controlled trial of transdermal nicotine in the treatment of attention deficit hyperactivity disorder.

Authors:  R Douglas Shytle; Archie A Silver; Berney J Wilkinson; Paul R Sanberg
Journal:  World J Biol Psychiatry       Date:  2002-07       Impact factor: 4.132

5.  Neuropsychological analyses of comorbidity between reading disability and attention deficit hyperactivity disorder: in search of the common deficit.

Authors:  Erik G Willcutt; Bruce F Pennington; Richard K Olson; Nomita Chhabildas; Jacqueline Hulslander
Journal:  Dev Neuropsychol       Date:  2005       Impact factor: 2.253

6.  Nicotinic mechanisms of memory: effects of acute local DHbetaE and MLA infusions in the basolateral amygdala.

Authors:  Nii A Addy; Aya Nakijama; Edward D Levin
Journal:  Brain Res Cogn Brain Res       Date:  2003-03

Review 7.  ADHD and smoking: from genes to brain to behavior.

Authors:  Francis Joseph McClernon; Scott Haden Kollins
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

8.  Neural substrates of decision making in adults with attention deficit hyperactivity disorder.

Authors:  Monique Ernst; Alane S Kimes; Edythe D London; John A Matochik; Dana Eldreth; Satya Tata; Carlo Contoreggi; Michelle Leff; Karen Bolla
Journal:  Am J Psychiatry       Date:  2003-06       Impact factor: 18.112

9.  Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

Authors:  David Michelson; Lenard Adler; Thomas Spencer; Frederick W Reimherr; Scott A West; Albert J Allen; Douglas Kelsey; Joachim Wernicke; Anthony Dietrich; Denái Milton
Journal:  Biol Psychiatry       Date:  2003-01-15       Impact factor: 13.382

10.  Differential effects of atomoxetine on executive functioning and lexical decision in attention-deficit/hyperactivity disorder and reading disorder.

Authors:  Christien G W de Jong; Séverine Van De Voorde; Herbert Roeyers; Ruth Raymaekers; Albert J Allen; Simone Knijff; Helene Verhelst; Alfons H Temmink; Leo M E Smit; Rob Rodriques-Pereira; Dirk Vandenberghe; Inge van Welsen; Liesbeth ter Schuren; Mazim Al-Hakim; Azad Amin; Laurens Vlasveld; Jaap Oosterlaan; Joseph A Sergeant
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-12       Impact factor: 2.576

View more
  33 in total

1.  Nucleus accumbens neuronal activity in freely behaving rats is modulated following acute and chronic methylphenidate administration.

Authors:  Samuel L Chong; Catherine M Claussen; Nachum Dafny
Journal:  Brain Res Bull       Date:  2012-01-13       Impact factor: 4.077

2.  Effects of intra-accumbal administration of dopamine and ionotropic glutamate receptor drugs on delay discounting performance in rats.

Authors:  Justin R Yates; Michael T Bardo
Journal:  Behav Neurosci       Date:  2017-10       Impact factor: 1.912

3.  The effects of stimulant medication on working memory functional connectivity in attention-deficit/hyperactivity disorder.

Authors:  Christina G Wong; Michael C Stevens
Journal:  Biol Psychiatry       Date:  2011-12-29       Impact factor: 13.382

4.  Atomoxetine modulates spontaneous and sensory-evoked discharge of locus coeruleus noradrenergic neurons.

Authors:  A Bari; G Aston-Jones
Journal:  Neuropharmacology       Date:  2012-07-20       Impact factor: 5.250

5.  Abnormal functional connectivity in children with attention-deficit/hyperactivity disorder.

Authors:  Dardo Tomasi; Nora D Volkow
Journal:  Biol Psychiatry       Date:  2011-12-06       Impact factor: 13.382

Review 6.  Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.

Authors:  Michael J Minzenberg
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

7.  Stereochemistry and neuropharmacology of a 'bath salt' cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebrates.

Authors:  Alexandre Vouga; Ryan A Gregg; Maryah Haidery; Anita Ramnath; Hassan K Al-Hassani; Christopher S Tallarida; David Grizzanti; Robert B Raffa; Garry R Smith; Allen B Reitz; Scott M Rawls
Journal:  Neuropharmacology       Date:  2014-12-09       Impact factor: 5.250

8.  Methylphenidate and atomoxetine enhance sensory-evoked neuronal activity in the visual thalamus of male rats.

Authors:  Rachel L Navarra; Brian D Clark; Gerard A Zitnik; Barry D Waterhouse
Journal:  Exp Clin Psychopharmacol       Date:  2013-10       Impact factor: 3.157

9.  Variable maternal stress in rats alters locomotor activity, social behavior, and recognition memory in the adult offspring.

Authors:  Christina A Wilson; Alvin V Terry
Journal:  Pharmacol Biochem Behav       Date:  2012-12-31       Impact factor: 3.533

Review 10.  The Association of SNAP25 Gene Polymorphisms in Attention Deficit/Hyperactivity Disorder: a Systematic Review and Meta-Analysis.

Authors:  Yun-Sheng Liu; Xuan Dai; Wei Wu; Fang-Fen Yuan; Xue Gu; Jian-Guo Chen; Ling-Qiang Zhu; Jing Wu
Journal:  Mol Neurobiol       Date:  2016-03-03       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.